Clinical trial of bromhexine in severe chronic bronchitics during winter
In a double-blind, controlled cross-over trial, the effect of the mucolytic drug bromhexine (24 mg or 48 mg daily) was compared with a placebo over a period of 14 weeks in 21 severe chronic bronchitics (mean FEV(1·0) 0·8 1.). Each of the three treatment regimes was continued for four weeks with inte...
Gardado en:
| Publicado en: | Thorax |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMJ Publishing Group
1972
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC469946/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/4561679/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.27.4.429 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|